share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Burrell Terry-Ann

SEC announcement ·  Jun 6 06:17
Summary by Futu AI
Terry-Ann Burrell, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on June 3, 2024. The transaction involved a grant of 13,097 shares of Class A Common Stock at no cost. Following this transaction, Burrell's direct holdings in the company increased to a total of 69,411 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of its employees with those of shareholders.
Terry-Ann Burrell, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on June 3, 2024. The transaction involved a grant of 13,097 shares of Class A Common Stock at no cost. Following this transaction, Burrell's direct holdings in the company increased to a total of 69,411 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of its employees with those of shareholders.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.